MumbaiA few moments ago
- Copy link
The IPO of the Anthem Biosciences received a good investors’ response and in three days it was 67.42 times subscribed.
The stock of drug manufacturer Anthem Biosyinsage Limited was listed in the market today at Rs 723 from its issue price of Rs 570 from Rs 570.
Company The share was listed at ₹ 723.05 on Bombay Stock Exchange i.e. BSE and Rs 723.10 on National Stock Exchange i.e. NSE. After the day -long trading, it climbed 1% to close at 730.
Target to raise ₹ 3,395.79 crore
This IPO for subscription was open from 14 to 16 July. Which received a good response from investors and in three days it subscribed to 67.42 times. Through this, the company wants to raise Rs 3,395.79 crore.
What does Anthem Biosciences Limited do?
Anthem Biosyinsage Limited began in 2006. It is an innovation and technology based company that works as a medicine research, development and manufacturing (CRDMO). The company also provides services to small and big biotech companies and large pharmaceutical companies globally.
